hypofractionated radiotherapy
Showing 1 - 25 of 5,355
Cervical Tumor, Adaptive Radiotherapy, Radiotherapy; Adverse Effect Trial in Beijing (Moderately hypofractionated adaptive
Recruiting
- Cervical Neoplasm
- +2 more
- Moderately hypofractionated adaptive radiotherapy (ART)+ High-dose rate (HDR) Brachytherapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 15, 2023
Esophageal Cancer Trial (Hypofractionated radiotherapy)
Not yet recruiting
- Esophageal Cancer
- Hypofractionated radiotherapy
- (no location specified)
Jan 18, 2023
Laryngeal Carcinoma Trial in Dallas (LT-SABR, IMRT)
Not yet recruiting
- Laryngeal Carcinoma
- LT-SABR
- IMRT
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 6, 2023
Malignant Breast Tumor Trial in Sao Paulo (Ultra-hypofractionated whole breast radiotherapy, Standard Radiation)
Recruiting
- Malignant Breast Neoplasm
- Ultra-hypofractionated whole breast radiotherapy
- Standard Radiation
-
Sao Paulo, SP, BrazilIBCC Oncologia
Dec 26, 2022
Soft Tissue Sarcoma Trial in Charleston (Hypofractionated Radiation Therapy)
Not yet recruiting
- Soft Tissue Sarcoma
- Hypofractionated Radiation Therapy
-
Charleston, South CarolinaMedical University of South Carolina
Mar 8, 2023
Prostate Cancer, Radiotherapy Side Effect Trial in Graz (Hypofractionated radiotherapy)
Terminated
- Prostate Cancer
- Radiotherapy Side Effect
- Hypofractionated radiotherapy
-
Graz, AustriaMedical University of Graz
Sep 29, 2022
Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1
Active, not recruiting
- Gastric or Gastroesophageal Junction Adenocarcinoma
- neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Jul 4, 2023
Glioblastoma Trial (Hypofractionated radiotherapy, Conventional radiotherapy, Temozolomide)
Not yet recruiting
- Glioblastoma
- Hypofractionated radiotherapy
- +2 more
- (no location specified)
Jun 27, 2022
NSCLC Stage III, Radiotherapy Side Effect, Frailty Trial (Photon, Proton)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
- +2 more
- Photon
- Proton
- (no location specified)
Sep 20, 2022
Prostate Cancer Trial in Heidelberg (Hypofractionated radiotherapy with photons, Hypofractionated radiotherapy with protons,
Recruiting
- Prostate Cancer
- Hypofractionated radiotherapy with photons
- +2 more
-
Heidelberg, GermanyUniversity Hospital Heidelberg
Nov 2, 2022
Breast Cancer Female Trial in São Paulo (adjuvant ultra-hypofractionated radiotherapy)
Completed
- Breast Cancer Female
- adjuvant ultra-hypofractionated radiotherapy
-
São Paulo, BrazilInstituto de Pesquisa Prevent Senior
Apr 30, 2023
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Not yet recruiting
- Recurrent Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 17, 2022
Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined
Not yet recruiting
- Lung Neoplasms
- Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
- Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
- (no location specified)
Jun 12, 2023
Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)
Not yet recruiting
- Prostate Cancer
- Radiotherapy standard
- Radiotherapy Hypo-FLAME
- (no location specified)
Jan 30, 2023
Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal
Recruiting
- Larynx Cancer Stage I
- Glottic Carcinoma
- Hypofractionated single vocal cord irradiation
- Whole laryngeal radiotherapy
-
Cairo, EgyptNational Cancer Institute, Cairo University
Jan 10, 2023
Ultra-hypofractionated Radiotherapy in Breast Cancer Patients
Recruiting
- Female Breast Cancer
- ultra-hypofractionated whole breast irradiation
-
Perugia, ItalyRadiation Oncology Section, Department of Medicine and Surgery,
Oct 16, 2022
Breast Cancer Trial in Hospitalet de Llobregat (Intraoperative Radiotherapy (IORT), Breast conservative surgery, External Beam
Recruiting
- Breast Cancer
- Intraoperative Radiotherapy (IORT)
- +2 more
-
Hospitalet de Llobregat, Barcelona, SpainEvelyn Martínez
Aug 11, 2022
Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- HLX10
- +2 more
- (no location specified)
Jun 29, 2022
Breast Cancer, Radiotherapy Side Effect Trial in Beijing (Ultra-fractionated radiation therapy)
Recruiting
- Breast Cancer
- Radiotherapy Side Effect
- Ultra-fractionated radiation therapy
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Mar 9, 2023
Soft Tissue Sarcoma Trial in Madison (Hypofractionated Radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- Hypofractionated Radiotherapy
-
Madison, WisconsinUniversity of Wisconsin
Mar 3, 2022
Soft Tissue Sarcoma, Retroperitoneal Sarcoma, Radiotherapy Side Effect Trial in Beijing (ultra-hypofractionated radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- +4 more
- ultra-hypofractionated radiotherapy
-
Beijing, Beijing, ChinaRadiotherapy Department of Cancer Hospital, Chinese Academy of M
Jan 25, 2022
Breast Cancer Trial in Barretos (Hypofractionation)
Recruiting
- Breast Cancer
- Hypofractionation
-
Barretos, São Paulo, BrazilRadiation Oncology Department
Aug 4, 2022
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Scottsdale, Jacksonville,
Active, not recruiting
- Stage I Breast Cancer AJCC v7
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023